Biondo Investment Advisors’s Eli Lilly LLY Stock Holding History

Biondo Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.7M	Sell	18,109 -211	-1%	-$214K	2.14%	12
2025 Q4	$19.7M	Sell	18,320 -135	-0.7%	-$129K	2.38%	10
2025 Q3	$14.1M	Buy	18,455 +109	+0.6%	+$81.1K	1.76%	15
2025 Q2	$14.3M	Buy	18,346 +242	+1%	+$188K	1.89%	14
2025 Q1	$15M	Buy	18,104 +163	+0.9%	+$136K	2.12%	12
2024 Q4	$13.9M	Buy	17,941 +117	+0.7%	+$96.9K	1.91%	14
2024 Q3	$15.8M	Buy	17,824 +109	+0.6%	+$98K	2.16%	13
2024 Q2	$16M	Buy	17,715 +315	+2%	+$252K	2.37%	11
2024 Q1	$13.5M	Buy	17,400 +277	+2%	+$197K	2.09%	14
2023 Q4	$9.98M	Buy	17,123 +524	+3%	+$306K	1.7%	17
2023 Q3	$8.92M	Buy	+16,599	New	+$8.55M	1.68%	17

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Biondo Investment Advisors's LLY Position: Q1 2026 in Review

Biondo Investment Advisors reduced its Eli Lilly (LLY) stake by 1.2% in Q1 2026, selling an estimated $214K and leaving 18,109 shares worth $16.7M. The position accounts for 2.14% of the portfolio, ranked #12.

Biondo Investment Advisors first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $19.7M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Biondo Investment Advisors held 18,109 shares of Eli Lilly worth $16.7M as of Q1 2026.
Biondo Investment Advisors sold 211 Eli Lilly shares in Q1 2026, an estimated $214K.
Eli Lilly made up 2.14% of Biondo Investment Advisors's portfolio in Q1 2026, its #12 holding.
Biondo Investment Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
Biondo Investment Advisors's Eli Lilly position peaked at $19.7M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.